brentuximab,doxorubicin hydrochloride,dacarbazine,filgrastim,pegfilgrastim,nivolumab,vinblastine sulfate
seagen,amgen,bms
['opdivo', 'lymphoma', 'adcetris', 'bristol', 'seagen']
bristol myers' opdivo keeps cancer at bay in more lymphoma patients than seagen's adcetris in phiii: #asco23 #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #healthcare #biotech #pharma 
Strategy & Competitive Marketing | Digital & Social Pharma | Life Sciences Investment | Cell & Gene Therapy | Vaccines